Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 9/10

vs
industry
vs
history
Cash to Debt No Debt
ALOG's Cash to Debt is ranked higher than
97% of the 189 Companies
in the Global Diagnostics & Research industry.

( Industry Median: 3.28 vs. ALOG: No Debt )
Ranked among companies with meaningful Cash to Debt only.
ALOG' s 10-Year Cash to Debt Range
Min: 1.19  Med: 10000.00 Max: No Debt
Current: No Debt
Equity to Asset 0.84
ALOG's Equity to Asset is ranked higher than
85% of the 172 Companies
in the Global Diagnostics & Research industry.

( Industry Median: 0.60 vs. ALOG: 0.84 )
Ranked among companies with meaningful Equity to Asset only.
ALOG' s 10-Year Equity to Asset Range
Min: 0.71  Med: 0.83 Max: 0.88
Current: 0.84
0.71
0.88
Interest Coverage No Debt
ALOG's Interest Coverage is ranked higher than
93% of the 100 Companies
in the Global Diagnostics & Research industry.

( Industry Median: 1009.34 vs. ALOG: No Debt )
Ranked among companies with meaningful Interest Coverage only.
ALOG' s 10-Year Interest Coverage Range
Min: 21.63  Med: 5098.38 Max: 9999.99
Current: No Debt
21.63
9999.99
F-Score: 6
Z-Score: 8.72
M-Score: -2.46
WACC vs ROIC
8.62%
8.52%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 7/10

vs
industry
vs
history
Operating margin (%) 6.98
ALOG's Operating margin (%) is ranked higher than
65% of the 182 Companies
in the Global Diagnostics & Research industry.

( Industry Median: -0.05 vs. ALOG: 6.98 )
Ranked among companies with meaningful Operating margin (%) only.
ALOG' s 10-Year Operating margin (%) Range
Min: -1.49  Med: 5.62 Max: 15.02
Current: 6.98
-1.49
15.02
Net-margin (%) 6.40
ALOG's Net-margin (%) is ranked higher than
74% of the 182 Companies
in the Global Diagnostics & Research industry.

( Industry Median: -1.79 vs. ALOG: 6.40 )
Ranked among companies with meaningful Net-margin (%) only.
ALOG' s 10-Year Net-margin (%) Range
Min: 0.87  Med: 5.68 Max: 10.5
Current: 6.4
0.87
10.5
ROE (%) 6.58
ALOG's ROE (%) is ranked higher than
65% of the 175 Companies
in the Global Diagnostics & Research industry.

( Industry Median: -1.52 vs. ALOG: 6.58 )
Ranked among companies with meaningful ROE (%) only.
ALOG' s 10-Year ROE (%) Range
Min: 0.88  Med: 5.88 Max: 14.98
Current: 6.58
0.88
14.98
ROA (%) 5.54
ALOG's ROA (%) is ranked higher than
73% of the 190 Companies
in the Global Diagnostics & Research industry.

( Industry Median: -3.05 vs. ALOG: 5.54 )
Ranked among companies with meaningful ROA (%) only.
ALOG' s 10-Year ROA (%) Range
Min: 0.68  Med: 4.97 Max: 11.24
Current: 5.54
0.68
11.24
ROC (Joel Greenblatt) (%) 12.84
ALOG's ROC (Joel Greenblatt) (%) is ranked higher than
60% of the 186 Companies
in the Global Diagnostics & Research industry.

( Industry Median: -2.58 vs. ALOG: 12.84 )
Ranked among companies with meaningful ROC (Joel Greenblatt) (%) only.
ALOG' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: -2.21  Med: 12.61 Max: 58.82
Current: 12.84
-2.21
58.82
Revenue Growth (3Y)(%) 2.70
ALOG's Revenue Growth (3Y)(%) is ranked lower than
62% of the 113 Companies
in the Global Diagnostics & Research industry.

( Industry Median: 6.10 vs. ALOG: 2.70 )
Ranked among companies with meaningful Revenue Growth (3Y)(%) only.
ALOG' s 10-Year Revenue Growth (3Y)(%) Range
Min: -10.4  Med: 5.90 Max: 15.9
Current: 2.7
-10.4
15.9
EBITDA Growth (3Y)(%) 9.60
ALOG's EBITDA Growth (3Y)(%) is ranked higher than
66% of the 104 Companies
in the Global Diagnostics & Research industry.

( Industry Median: 2.30 vs. ALOG: 9.60 )
Ranked among companies with meaningful EBITDA Growth (3Y)(%) only.
ALOG' s 10-Year EBITDA Growth (3Y)(%) Range
Min: -41.1  Med: -0.65 Max: 62.5
Current: 9.6
-41.1
62.5
EPS Growth (3Y)(%) 26.90
ALOG's EPS Growth (3Y)(%) is ranked higher than
84% of the 102 Companies
in the Global Diagnostics & Research industry.

( Industry Median: 1.40 vs. ALOG: 26.90 )
Ranked among companies with meaningful EPS Growth (3Y)(%) only.
ALOG' s 10-Year EPS Growth (3Y)(%) Range
Min: -56  Med: 0.10 Max: 127.6
Current: 26.9
-56
127.6
» ALOG's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

Q3 2014

ALOG Guru Trades in Q3 2014

Richard Snow 19,558 sh (New)
Jim Simons 103,054 sh (+1301.33%)
Paul Tudor Jones 11,706 sh (+74.72%)
NWQ Managers 365,630 sh (+23.38%)
Chuck Royce 625,595 sh (-1.34%)
Joel Greenblatt 82,530 sh (-40.05%)
» More
Q4 2014

ALOG Guru Trades in Q4 2014

Richard Snow 59,330 sh (+203.35%)
NWQ Managers 471,165 sh (+28.86%)
Chuck Royce 549,895 sh (unchged)
Joel Greenblatt Sold Out
Chuck Royce 549,895 sh (-12.10%)
Jim Simons 67,764 sh (-34.24%)
Paul Tudor Jones 6,210 sh (-46.95%)
» More
Q1 2015

ALOG Guru Trades in Q1 2015

Richard Snow 80,345 sh (+35.42%)
NWQ Managers 530,517 sh (+12.60%)
Chuck Royce 576,495 sh (+4.84%)
Jim Simons Sold Out
Paul Tudor Jones 3,600 sh (-42.03%)
» More
Q2 2015

ALOG Guru Trades in Q2 2015

Paul Tudor Jones 8,700 sh (+141.67%)
Richard Snow 136,390 sh (+69.76%)
NWQ Managers 552,722 sh (+4.19%)
Chuck Royce 539,395 sh (-6.44%)
» More
» Details

Insider Trades

Latest Guru Trades with ALOG

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Ratios

vs
industry
vs
history
P/E(ttm) 30.03
ALOG's P/E(ttm) is ranked lower than
54% of the 84 Companies
in the Global Diagnostics & Research industry.

( Industry Median: 30.10 vs. ALOG: 30.03 )
Ranked among companies with meaningful P/E(ttm) only.
ALOG' s 10-Year P/E(ttm) Range
Min: 10.78  Med: 31.73 Max: 412.04
Current: 30.03
10.78
412.04
Forward P/E 17.42
ALOG's Forward P/E is ranked higher than
59% of the 58 Companies
in the Global Diagnostics & Research industry.

( Industry Median: 20.12 vs. ALOG: 17.42 )
Ranked among companies with meaningful Forward P/E only.
N/A
PE(NRI) 31.10
ALOG's PE(NRI) is ranked lower than
54% of the 84 Companies
in the Global Diagnostics & Research industry.

( Industry Median: 30.30 vs. ALOG: 31.10 )
Ranked among companies with meaningful PE(NRI) only.
ALOG' s 10-Year PE(NRI) Range
Min: 15.03  Med: 32.92 Max: 172.94
Current: 31.1
15.03
172.94
P/B 1.91
ALOG's P/B is ranked higher than
74% of the 168 Companies
in the Global Diagnostics & Research industry.

( Industry Median: 3.33 vs. ALOG: 1.91 )
Ranked among companies with meaningful P/B only.
ALOG' s 10-Year P/B Range
Min: 0.82  Med: 1.75 Max: 2.53
Current: 1.91
0.82
2.53
P/S 1.91
ALOG's P/S is ranked higher than
65% of the 184 Companies
in the Global Diagnostics & Research industry.

( Industry Median: 2.99 vs. ALOG: 1.91 )
Ranked among companies with meaningful P/S only.
ALOG' s 10-Year P/S Range
Min: 0.78  Med: 1.83 Max: 3.09
Current: 1.91
0.78
3.09
PFCF 50.72
ALOG's PFCF is ranked lower than
67% of the 67 Companies
in the Global Diagnostics & Research industry.

( Industry Median: 25.28 vs. ALOG: 50.72 )
Ranked among companies with meaningful PFCF only.
ALOG' s 10-Year PFCF Range
Min: 13.81  Med: 33.13 Max: 171.59
Current: 50.72
13.81
171.59
POCF 32.72
ALOG's POCF is ranked lower than
65% of the 84 Companies
in the Global Diagnostics & Research industry.

( Industry Median: 20.83 vs. ALOG: 32.72 )
Ranked among companies with meaningful POCF only.
ALOG' s 10-Year POCF Range
Min: 9  Med: 20.41 Max: 82.49
Current: 32.72
9
82.49
EV-to-EBIT 23.79
ALOG's EV-to-EBIT is ranked lower than
61% of the 93 Companies
in the Global Diagnostics & Research industry.

( Industry Median: 20.60 vs. ALOG: 23.79 )
Ranked among companies with meaningful EV-to-EBIT only.
ALOG' s 10-Year EV-to-EBIT Range
Min: -1866  Med: 24.30 Max: 388.6
Current: 23.79
-1866
388.6
PEG 1.12
ALOG's PEG is ranked higher than
85% of the 41 Companies
in the Global Diagnostics & Research industry.

( Industry Median: 3.25 vs. ALOG: 1.12 )
Ranked among companies with meaningful PEG only.
ALOG' s 10-Year PEG Range
Min: 0.81  Med: 2.89 Max: 213.51
Current: 1.12
0.81
213.51
Shiller P/E 33.88
ALOG's Shiller P/E is ranked lower than
58% of the 55 Companies
in the Global Diagnostics & Research industry.

( Industry Median: 26.03 vs. ALOG: 33.88 )
Ranked among companies with meaningful Shiller P/E only.
ALOG' s 10-Year Shiller P/E Range
Min: 15.03  Med: 33.35 Max: 53.98
Current: 33.88
15.03
53.98
Current Ratio 4.79
ALOG's Current Ratio is ranked higher than
75% of the 182 Companies
in the Global Diagnostics & Research industry.

( Industry Median: 2.49 vs. ALOG: 4.79 )
Ranked among companies with meaningful Current Ratio only.
ALOG' s 10-Year Current Ratio Range
Min: 2.82  Med: 5.25 Max: 7.99
Current: 4.79
2.82
7.99
Quick Ratio 3.04
ALOG's Quick Ratio is ranked higher than
62% of the 182 Companies
in the Global Diagnostics & Research industry.

( Industry Median: 2.21 vs. ALOG: 3.04 )
Ranked among companies with meaningful Quick Ratio only.
ALOG' s 10-Year Quick Ratio Range
Min: 2.13  Med: 3.90 Max: 6.15
Current: 3.04
2.13
6.15
Days Inventory 161.01
ALOG's Days Inventory is ranked lower than
83% of the 147 Companies
in the Global Diagnostics & Research industry.

( Industry Median: 77.75 vs. ALOG: 161.01 )
Ranked among companies with meaningful Days Inventory only.
ALOG' s 10-Year Days Inventory Range
Min: 89.07  Med: 116.21 Max: 147.7
Current: 161.01
89.07
147.7
Days Sales Outstanding 70.53
ALOG's Days Sales Outstanding is ranked lower than
58% of the 161 Companies
in the Global Diagnostics & Research industry.

( Industry Median: 65.30 vs. ALOG: 70.53 )
Ranked among companies with meaningful Days Sales Outstanding only.
ALOG' s 10-Year Days Sales Outstanding Range
Min: 41.69  Med: 68.25 Max: 79.41
Current: 70.53
41.69
79.41

Dividend & Buy Back

vs
industry
vs
history
Dividend Yield 0.51
ALOG's Dividend Yield is ranked lower than
85% of the 80 Companies
in the Global Diagnostics & Research industry.

( Industry Median: 1.42 vs. ALOG: 0.51 )
Ranked among companies with meaningful Dividend Yield only.
ALOG' s 10-Year Dividend Yield Range
Min: 0.41  Med: 0.66 Max: 1.6
Current: 0.51
0.41
1.6
Dividend Payout 0.15
ALOG's Dividend Payout is ranked higher than
98% of the 49 Companies
in the Global Diagnostics & Research industry.

( Industry Median: 0.33 vs. ALOG: 0.15 )
Ranked among companies with meaningful Dividend Payout only.
ALOG' s 10-Year Dividend Payout Range
Min: 0.04  Med: 0.19 Max: 8
Current: 0.15
0.04
8
Yield on cost (5-Year) 0.51
ALOG's Yield on cost (5-Year) is ranked lower than
88% of the 85 Companies
in the Global Diagnostics & Research industry.

( Industry Median: 1.60 vs. ALOG: 0.51 )
Ranked among companies with meaningful Yield on cost (5-Year) only.
ALOG' s 10-Year Yield on cost (5-Year) Range
Min: 0.41  Med: 0.66 Max: 1.6
Current: 0.51
0.41
1.6
Share Buyback Rate -0.30
ALOG's Share Buyback Rate is ranked higher than
79% of the 111 Companies
in the Global Diagnostics & Research industry.

( Industry Median: -3.60 vs. ALOG: -0.30 )
Ranked among companies with meaningful Share Buyback Rate only.
ALOG' s 10-Year Share Buyback Rate Range
Min: 3.2  Med: -0.50 Max: -1.3
Current: -0.3

Valuation & Return

vs
industry
vs
history
Price/Net Cash 50.48
ALOG's Price/Net Cash is ranked lower than
93% of the 60 Companies
in the Global Diagnostics & Research industry.

( Industry Median: 10.50 vs. ALOG: 50.48 )
Ranked among companies with meaningful Price/Net Cash only.
ALOG' s 10-Year Price/Net Cash Range
Min: 3.17  Med: 7.76 Max: 124.64
Current: 50.48
3.17
124.64
Price/Net Current Asset Value 3.35
ALOG's Price/Net Current Asset Value is ranked higher than
78% of the 108 Companies
in the Global Diagnostics & Research industry.

( Industry Median: 7.45 vs. ALOG: 3.35 )
Ranked among companies with meaningful Price/Net Current Asset Value only.
ALOG' s 10-Year Price/Net Current Asset Value Range
Min: 1.28  Med: 2.52 Max: 4.77
Current: 3.35
1.28
4.77
Price/Tangible Book 2.40
ALOG's Price/Tangible Book is ranked higher than
72% of the 145 Companies
in the Global Diagnostics & Research industry.

( Industry Median: 4.76 vs. ALOG: 2.40 )
Ranked among companies with meaningful Price/Tangible Book only.
ALOG' s 10-Year Price/Tangible Book Range
Min: 0.93  Med: 1.84 Max: 3.17
Current: 2.4
0.93
3.17
Price/Projected FCF 1.57
ALOG's Price/Projected FCF is ranked higher than
63% of the 70 Companies
in the Global Diagnostics & Research industry.

( Industry Median: 2.01 vs. ALOG: 1.57 )
Ranked among companies with meaningful Price/Projected FCF only.
ALOG' s 10-Year Price/Projected FCF Range
Min: 0.79  Med: 1.39 Max: 2.07
Current: 1.57
0.79
2.07
Price/Median PS Value 1.05
ALOG's Price/Median PS Value is ranked lower than
54% of the 158 Companies
in the Global Diagnostics & Research industry.

( Industry Median: 1.02 vs. ALOG: 1.05 )
Ranked among companies with meaningful Price/Median PS Value only.
ALOG' s 10-Year Price/Median PS Value Range
Min: 0.43  Med: 0.93 Max: 1.53
Current: 1.05
0.43
1.53
Price/Peter Lynch Fair Value 2.91
ALOG's Price/Peter Lynch Fair Value is ranked lower than
77% of the 26 Companies
in the Global Diagnostics & Research industry.

( Industry Median: 1.86 vs. ALOG: 2.91 )
Ranked among companies with meaningful Price/Peter Lynch Fair Value only.
ALOG' s 10-Year Price/Peter Lynch Fair Value Range
Min: 0.82  Med: 2.37 Max: 11.42
Current: 2.91
0.82
11.42
Price/Graham Number 1.78
ALOG's Price/Graham Number is ranked higher than
65% of the 63 Companies
in the Global Diagnostics & Research industry.

( Industry Median: 2.82 vs. ALOG: 1.78 )
Ranked among companies with meaningful Price/Graham Number only.
ALOG' s 10-Year Price/Graham Number Range
Min: 1  Med: 1.62 Max: 12.17
Current: 1.78
1
12.17
Earnings Yield (Greenblatt) (%) 4.15
ALOG's Earnings Yield (Greenblatt) (%) is ranked higher than
69% of the 183 Companies
in the Global Diagnostics & Research industry.

( Industry Median: 0.40 vs. ALOG: 4.15 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) (%) only.
ALOG' s 10-Year Earnings Yield (Greenblatt) (%) Range
Min: 0.3  Med: 3.90 Max: 8.3
Current: 4.15
0.3
8.3
Forward Rate of Return (Yacktman) (%) 12.59
ALOG's Forward Rate of Return (Yacktman) (%) is ranked higher than
58% of the 55 Companies
in the Global Diagnostics & Research industry.

( Industry Median: 10.53 vs. ALOG: 12.59 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) (%) only.
ALOG' s 10-Year Forward Rate of Return (Yacktman) (%) Range
Min: -23.6  Med: 7.10 Max: 36.8
Current: 12.59
-23.6
36.8

Analyst Estimate

Jul15 Jul16 Jul17 Jul18
Revenue(Mil) 537 578 624 687
EPS($) 3.29 4.54 5.70 6.61
EPS without NRI($) 3.29 4.54 5.70 6.61

Business Description

Industry: Medical Diagnostics & Research » Diagnostics & Research
Compare:A, ROP, GRMN, HXGBY, TRMB » details
Traded in other countries:AJM.Germany,
Analogic Corporation was incorporated in the Commonwealth of Massachusetts in November 1967. The company is a technology company that designs and manufactures medical imaging and security systems and subsystems sold to original equipment manufacturers, or OEMs, and end users mainly in the healthcare and airport security markets. Its business is strategically aligned into three segments: Medical Imaging, Ultrasound, and Security Technology. Medical Imaging mainly includes systems and subsystems for CT and MRI medical imaging equipment as well as state-of-the-art, Selenium-based detectors for screening and diagnostic applications in mammography. Ultrasound includes ultrasound systems and transducers primarily in the urology, surgery (including robotic assisted surgery), anesthesia, and point-of-care markets. Security Technology includes advanced threat detecting CT systems utilizing its expertise in advanced imaging technology and primarily used in the checked baggage screening at airports worldwide. Its competitors include General Electric Corporation, Koninklijke Philips Electronics N.V., Hitachi Medical Corporation, and Fujifilm. Its manufacturing facilities are subject to numerous environmental laws and regulations, particularly with respect to industrial waste and emissions.
» More Articles for ALOG

Headlines

Articles On GuruFocus.com
AMD Embedded Radeon(TM) HD 7850 GPU Accelerates Medical Imaging Jan 12 2015 
Could These Science Stocks Provide Big Gains? Mar 11 2012 
Weekly Top Insider Buys: Health Care REIT Inc., Human Genome Sciences Inc., Conseco Inc., Universal Jan 02 2010 
Analogic Corp. Reports Operating Results (10-K) Sep 29 2009 
Analogic Corp. (ALOG) Files Quarterly Report for the Period Ended on 2008-10-31 Dec 15 2008 
Analogic Corporation Announces Cash Dividend for Its First Quarter Dec 09 2008 
Analogic Corporation Announces Results for Its First Quarter Ended October 31, 2008 Dec 09 2008 

More From Other Websites
Edited Transcript of ALOG earnings conference call or presentation 4-Jun-15 9:00pm GMT Jun 26 2015
Analogic Congratulates Siemens on Achieving FDA Milestone Jun 11 2015
ANALOGIC CORP Financials Jun 11 2015
Logitech Brings Novel Keyboard for New Age Living Rooms - Analyst Blog Jun 11 2015
10-Q for Analogic Corp. Jun 10 2015
FLIR Systems Equips Firefighters with New Cameras - Analyst Blog Jun 09 2015
ANALOGIC CORP Files SEC form 10-Q, Quarterly Report Jun 08 2015
Company News for June 08, 2015 - Corporate Summary Jun 08 2015
Analogic posts 3Q profit Jun 04 2015
Analogic posts 3Q profit Jun 04 2015
ANALOGIC CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial... Jun 04 2015
Analogic Announces Financial Results for the Third Quarter Ended April 30, 2015 and Declares... Jun 04 2015
Q3 2015 Analogic Corp Earnings Release - After Market Close Jun 04 2015
ANALOGIC CORP Files SEC form 8-K, Change in Directors or Principal Officers, Other Events, Financial... Mar 30 2015
UPDATE: Brean Capital Upgrades Analogic Following Marketing Day Mar 24 2015
ANALOGIC CORP Files SEC form 8-K, Changes in Registrant's Certifying Accountant, Financial... Mar 13 2015
ANALOGIC CORP Files SEC form 10-Q, Quarterly Report Mar 11 2015
After-hours buzz: Weibo, Google, Verifone & more Mar 10 2015
ANALOGIC CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial... Mar 10 2015
Analogic posts 2Q profit Mar 10 2015

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK